location includes a clean room
for trial testing of customer
products, and a technology
showroom for demonstrations
and customer training.
At this year’s INTERPHEX
Booth 2221, MG America is
showcasing its next-generation
PLANETA 200 capsule filler
along with a sampling of equipment from its new exclusive
U.S., Canada, and Puerto Rico
supply deal with Italy’s Axomatic covering emulsifying equipment and tube fillers.
Pharmaceutical Processing asked MG America President
Fabio Trippodo about the company’s success as it marks its
30th anniversary, along with details of the company’s latest
technology, equipment, and services.
Q:What changes have you seen in the pharmaceutical market over the last 30 years
and how did MG America respond to those changes?
Fabio Trippodo: On the processing side, as time passes the
pharmaceutical industry has demanded increasingly accurate
dosages for its products, as well as the precise ability to
control proper dosages during and after process completion.
MG America has responded to this challenge by continuously
improving the accuracy of its capsule fillers dosing system,
and by creating integrated weighing verification systems
capable of seamless equipment integration.
In addition, requests for more detailed validation
documentation and validation support has necessitated
an uptick in validation experts within the company. MG
America has significantly invested in skilled resources
specializing in validation support, and will
continue to do so as needs get more and
more stringent and exacting.
The trends in packaging equipment predominantly concern versatility. Through the years, the
pharma industry has largely moved away from
single-format, lone-purpose machinery, instead
favoring equipment that can deftly handle a variety of formats and, preferably, serve more than
one purpose on a packaging line. MG America has responded by introducing equipment able to handle a vast array of
formats, and designed with tool-free changeover features
that increase flexibility and reduce line downtime.
Rules and regulations also have significantly impacted
machine designs, particularly pertaining to user accessibility, ergonomics, and software/control system simplicity. MG
America has embraced the challenge of adapting equipment
to the strict parameters set by the pharmaceutical industry,
especially those relating to operator and consumer safety.
Q:Your product portfolio includes capsule
fillers, tablet presses,
material handling equipment,
granulators, check weighing
and vision inspection
mixers, and more. In today’s
pharmaceutical market, which
of these equipment options
seem to be generating the
most interest and why?
Trippodo: Despite trends toward more innovative medication formats, oral solid dose products still dominate the
North American marketplace. That said, our capsule filling
equipment has continued to be extremely popular.
For example, at INTERPHEX this year MG America will
showcase its next-generation PLANETA 200 Capsule Filler,
the latest evolution in a line of well-established continuous
The PLANETA 200 produces up to 200,000 capsules per
hour, but its primary advantage is its premium flexibility:
Its modular design results in a highly configurable platform
suitable for a wide array of production requirements, including an ability to fit several dosing units simultaneously,
enabling one capsule to be filled with differing products.
Dosing units ascribe to a “no capsule, no dosage” concept, ensuring superior machine cleaning as well as reduction of both product waste and its exposure to the greater
The PLANETA 200 also is scalable. It can, for example,
initially be configured for medium speeds, then upgraded
later for maximum speeds, reaching different performances
depending on the number and type of dosing units installed.
Its weight control system also can be upgraded
post-installation; this includes facets as simple as
statistical control of capsule gross weight up to
the highly advanced MultiNETT system, which
allows in-process net weight checks of each
capsule and, in the case of same-capsule dosing
combinations each dosed product.
For tablet manufacturers, MG America is a dis-
tributor in the U.S., Canada, and Puerto Rico for a
line of tablet presses from Germany-based machinery manu-
facturer kg-pharma. The new relationship marks MG America’s
first foray into the North American tablet press marketplace.
The three-machine series is suitable for both R&D and pilot
scale production, with the most high-production press, the
Futorque X- 1, capable of producing up to 108,000 tablets
per hour. Each machine features automatic weight regulation by filling depth, and comes with a fully instrumented
R&D package including specialized software. Containment
also is available on each press.